What the Iran War Means for Pharma Supply Chains - Takeaways - MDSpire

What the Iran War Means for Pharma Supply Chains

Argon & Co’s Michel Savini discusses the medicines most exposed to geopolitical instability, and why scenario planning remains underused across life sciences

  • June 29, 2026

  • 8 min

Share

  • 1

    Pharmaceutical supply chains face renewed pressure from geopolitical instability, including the Iran conflict and the war in Ukraine.

  • 2

    Only 22% of life sciences firms are preparing for supply chain disruptions, despite 62% feeling pressure to reduce operational costs.

  • 3

    Medicines requiring refrigeration, such as biologics and vaccines, are particularly vulnerable to geopolitical disruptions affecting transport.

  • 4

    Energy market disruptions due to geopolitical instability can increase pharmaceutical manufacturing costs and affect medicine availability.

  • 5

    Companies must adopt strategic supply chain designs, including dual sourcing and increased safety stock, to enhance resilience.

Original Source(s)

What the Iran War Means for Pharma Supply Chains

  • June 29, 2026

Related Content

Fujifilm and HORIBA Develop Inline Raman System for Biomanufacturing

The system is designed for real-time monitoring of cell culture and purification, with Fujifilm reporting about a 10 percent yield improvement in antibody purification tests

  • June 29, 2026

  • 2 min
Radiotherapy-synergized in situ hydrogel vaccine with engineered Lactococcus lactis FOLactis potentiates anti-tumor immunity in pancreatic cancer

Alternative Isoforms May Refine Variant Interpretation

Long-read transcript sequencing uncovered protein-altering variants missed by reference transcript analyses and identified functional effects for a lung-specific DPP9 isoform.